Yibing Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yibing Huang has a total of 229 co-authors. Here are the top co-authors by number of shared publications:
- Yuxin Chen
Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, Jilin University, Changchun, China
28 shared publications Hua Wang
China–Japan Union Hospital of Jilin University, Changchun, 130031, People's Republic of China
13 shared publicationsLi Xu
Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, Jilin University, Changchun, 130021, PR China
11 shared publications- Xue-Zhong Zhang
Key Laboratory of Molecular Enzymology and Engineering of Ministry of EducationJilin UniversityChangchun 130021, China
10 shared publications - Quan Luo
Jilin University
8 shared publications Rui-Zhen Hou
Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, Jilin University, Changchun 130021, P. R. China
7 shared publications
Latest Publications
- 7 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Machine Learning-Enhanced Three-Channel Cu-Pt Bimetallic Nanozyme Sensor Array for Multi-Class Pesticide Fingerprint Discrimination
Pesticide residues with diverse toxicities and synergistic effects demand rapid, multiplexed discrimination methods beyond conventional single-analyte assays. Here, we report a machine-learning-enhanced three-channel colorimetric sensor array based on Cu-Pt bimetallic nanozymes for multi-class pesticide fingerprint recognition. The single CuPtBN receptor integrates oxidase-, laccase-, and superoxide dismutase-like activities, generating three orthogonal optical response channels that capture differential inhibition and promotion effects from structurally similar pesticides. By coupling these multidimensional signals with “classification-regression” dual-loop machine learning models, the platform achieves concentration-independent qualitative identification and precise quantitative prediction, with 100% classification accuracy for nine representative pesticides and reliable predictive capability for nonlinear-response analytes. In blind tests and real agricultural samples, the system accurately identified pesticide species with prediction errors below 5% and recoveries of 85−105%. This work establishes a simplified yet information-rich multichannel nanozyme sensing strategy, highlighting its promise for high-throughput food safety screening and intelligent agrochemical monitoring.
- 7 August 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Machine Learning-Enhanced Three-Channel Cu-Pt Bimetallic Nanozyme Sensor Array for Multi-Class Pesticide Fingerprint Discrimination
Pesticide residues with diverse toxicities and synergistic effects demand rapid, multiplexed discrimination methods beyond conventional single-analyte assays. Here, we report a machine-learning-enhanced three-channel colorimetric sensor array based on Cu-Pt bimetallic nanozymes for multi-class pesticide fingerprint recognition. The single CuPtBN receptor integrates oxidase-, laccase-, and superoxide dismutase-like activities, generating three orthogonal optical response channels that capture differential inhibition and promotion effects from structurally similar pesticides. By coupling these multidimensional signals with “classification-regression” dual-loop machine learning models, the platform achieves concentration-independent qualitative identification and precise quantitative prediction, with 100% classification accuracy for nine representative pesticides and reliable predictive capability for nonlinear-response analytes. In blind tests and real agricultural samples, the system accurately identified pesticide species with prediction errors below 5% and recoveries of 85−105%. This work establishes a simplified yet information-rich multichannel nanozyme sensing strategy, highlighting its promise for high-throughput food safety screening and intelligent agrochemical monitoring.
- 7 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (15) , 22311-22322
Reprogramming Cascade Catalysis via Protein-Directed Interfacial Assembly of Spatially Ordered Clusterzymes for Enhanced Antioxidant Treatment
Precise spatial arrangement of catalytic centers is essential to emulate the efficiency of natural enzymatic cascades. Herein, we report a protein-mediated interfacial self-assembly strategy to construct vesicle-like proteinosomes with spatially arranged gold clusterzymes (AuNEs) to enhance multienzyme cascade catalysis. AuNEs were synthesized in situ within the confined cavity of a stable cyclic SP1 protein scaffold, genetically engineered with a Cysteine-Cysteine-Tyrosine (CCY) peptide to control cluster nucleation and growth. Metal doping with copper (Cu) and cadmium (Cd) yielded catalytically distinct Au-CuNEs and Au-CdNEs, exhibiting superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT)-like activities. These functionally complementary clusterzymes coassembled into size-tunable, ordered proteinosomes via electrostatic interactions with cetyltrimethylammonium bromide, enabling dense catalytic packing and proximity-enhanced reactions. The resulting proteinosomes displayed efficient cellular uptake and significantly improved reactive oxygen species (ROS) scavenging in Caenorhabditis elegans. This work presents a spatially programmable platform for synergistic catalysis, offering a promising approach for treating ROS-related diseases.
- 7 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (15) , 22311-22322
Reprogramming Cascade Catalysis via Protein-Directed Interfacial Assembly of Spatially Ordered Clusterzymes for Enhanced Antioxidant Treatment
Precise spatial arrangement of catalytic centers is essential to emulate the efficiency of natural enzymatic cascades. Herein, we report a protein-mediated interfacial self-assembly strategy to construct vesicle-like proteinosomes with spatially arranged gold clusterzymes (AuNEs) to enhance multienzyme cascade catalysis. AuNEs were synthesized in situ within the confined cavity of a stable cyclic SP1 protein scaffold, genetically engineered with a Cysteine-Cysteine-Tyrosine (CCY) peptide to control cluster nucleation and growth. Metal doping with copper (Cu) and cadmium (Cd) yielded catalytically distinct Au-CuNEs and Au-CdNEs, exhibiting superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT)-like activities. These functionally complementary clusterzymes coassembled into size-tunable, ordered proteinosomes via electrostatic interactions with cetyltrimethylammonium bromide, enabling dense catalytic packing and proximity-enhanced reactions. The resulting proteinosomes displayed efficient cellular uptake and significantly improved reactive oxygen species (ROS) scavenging in Caenorhabditis elegans. This work presents a spatially programmable platform for synergistic catalysis, offering a promising approach for treating ROS-related diseases.
- 12 February 2026
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 27 (3) , 2137-2147
Peptide-Directed Chiral Gold Nanozymes for Asymmetric Polymerization and Chirality-Selective Cytotoxicity
Precise control over macromolecular chirality is critical for molecular recognition and targeted biological interventions. Herein, we report a pair of chiral gold nanozymes (l-/d-AuNEs) that mimic horseradish peroxidase (HRP)-like activity to catalyze the oxidative coupling of chiral phenolic monomers in a cellular environment. By introducing peptide ligands with both amino-acid-based configurational chirality and secondary structural chirality, the nanozymes enable high-yield enantioselective polymerization of the chiral Ritodrine (RITO), leading to the formation of enantiomeric dimers and high-molecular-weight polymers. The resulting polymers, Poly-l-RITO and Poly-d-RITO, exhibit significantly enhanced cytotoxicity relative to the monomer, with Poly-d-RITO showing a notably higher pro-apoptotic effect. Mechanistic studies reveal that Poly-d-RITO preferentially accumulates at the cell membrane and induces more severe membrane damage. These findings reveal a chirality-dependent biointerface effect and highlight the potential of nanozyme-driven asymmetric polymerization as an alternative strategy for chiral drug development and targeted cancer therapy.
- 12 February 2026
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 27 (3) , 2137-2147
Peptide-Directed Chiral Gold Nanozymes for Asymmetric Polymerization and Chirality-Selective Cytotoxicity
Precise control over macromolecular chirality is critical for molecular recognition and targeted biological interventions. Herein, we report a pair of chiral gold nanozymes (l-/d-AuNEs) that mimic horseradish peroxidase (HRP)-like activity to catalyze the oxidative coupling of chiral phenolic monomers in a cellular environment. By introducing peptide ligands with both amino-acid-based configurational chirality and secondary structural chirality, the nanozymes enable high-yield enantioselective polymerization of the chiral Ritodrine (RITO), leading to the formation of enantiomeric dimers and high-molecular-weight polymers. The resulting polymers, Poly-l-RITO and Poly-d-RITO, exhibit significantly enhanced cytotoxicity relative to the monomer, with Poly-d-RITO showing a notably higher pro-apoptotic effect. Mechanistic studies reveal that Poly-d-RITO preferentially accumulates at the cell membrane and induces more severe membrane damage. These findings reveal a chirality-dependent biointerface effect and highlight the potential of nanozyme-driven asymmetric polymerization as an alternative strategy for chiral drug development and targeted cancer therapy.
- 2 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
From Cellular Organization to Synthetic Platforms: Liquid–Liquid Phase Separation as a Framework for Functional Biomolecular Condensates
Liquid-liquid phase separation (LLPS) is a fundamental biophysical process driving the formation of dynamic biomolecular condensates, which spatially organize cellular biochemistry without membrane delimitation. These condensates arise from multivalent, weak interactions among intrinsically disordered proteins, modular interaction motifs, and RNA scaffolds, enabling highly tunable and reversible compartmentalization of biomolecules. This phase behavior regulates critical cellular functions such as gene expression, signal transduction, and stress response, while its dysregulation contributes to pathological aggregation and disease. Recent advances leverage LLPS principles to design synthetic condensates with controllable composition, properties, and activities. Combining structural insights, quantitative phase behavior, and synthetic biology tools, engineered condensates have been developed for enhanced catalysis, metabolic control, targeted drug delivery, and biosensing. This review summarizes the molecular mechanisms, design strategies, and translational prospects of LLPS-mediated condensates, thereby paving the way for future exploration at the interface of cellular biophysics and bioengineering.
- 2 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
From Cellular Organization to Synthetic Platforms: Liquid–Liquid Phase Separation as a Framework for Functional Biomolecular Condensates
Liquid-liquid phase separation (LLPS) is a fundamental biophysical process driving the formation of dynamic biomolecular condensates, which spatially organize cellular biochemistry without membrane delimitation. These condensates arise from multivalent, weak interactions among intrinsically disordered proteins, modular interaction motifs, and RNA scaffolds, enabling highly tunable and reversible compartmentalization of biomolecules. This phase behavior regulates critical cellular functions such as gene expression, signal transduction, and stress response, while its dysregulation contributes to pathological aggregation and disease. Recent advances leverage LLPS principles to design synthetic condensates with controllable composition, properties, and activities. Combining structural insights, quantitative phase behavior, and synthetic biology tools, engineered condensates have been developed for enhanced catalysis, metabolic control, targeted drug delivery, and biosensing. This review summarizes the molecular mechanisms, design strategies, and translational prospects of LLPS-mediated condensates, thereby paving the way for future exploration at the interface of cellular biophysics and bioengineering.
- 16 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (39) , 55199-55212
Atomic-Level Engineering of Protein-Templated Gold Clusterzymes with Tunable Fluorescence and Multi-Enzyme Activities for Antiaging Treatment
Atomic precision synthesis and modulation of nanozymes are critical for evaluating their performance and developing functional applications. Herein, we developed an in situ strategy for the controlled synthesis of gold clusterzymes (AuCEs) within the confined cavities of the protein scaffolds. Using a stable dodecameric protein (SP1) as a ligand, we fused a short peptide containing the CCY sequence (SP1-CCY) to the N-terminus of SP1, which is located within its cyclic structure. In this design, cysteine and tyrosine synergistically chelate and reduce Au ions, while the confined protein structure restricts cluster growth, leading to the formation of a 25-gold atom (Au25) nanocluster with strong fluorescence and peroxidase-like activity. Unlike chemical ligands, protein scaffolds offer atomic-level precision and allow for site-specific modulation of the local environment through rational mutations, such as L9D, L9I, and E73I/L9I. This allows precise control of both fluorescence and enzymatic activity via protein engineering. Additionally, heteroatom doping of the Au core with copper endows the AuCEs with significant superoxide dismutase-like activity. Antioxidant assays demonstrate that the optimized AuCEs exhibit potent reactive oxygen species scavenging activity, providing significant protection to Caenorhabditis elegans from oxidative stress and highlighting their potential as therapeutic candidates for aging-related diseases.
- 16 September 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (39) , 55199-55212
Atomic-Level Engineering of Protein-Templated Gold Clusterzymes with Tunable Fluorescence and Multi-Enzyme Activities for Antiaging Treatment
Atomic precision synthesis and modulation of nanozymes are critical for evaluating their performance and developing functional applications. Herein, we developed an in situ strategy for the controlled synthesis of gold clusterzymes (AuCEs) within the confined cavities of the protein scaffolds. Using a stable dodecameric protein (SP1) as a ligand, we fused a short peptide containing the CCY sequence (SP1-CCY) to the N-terminus of SP1, which is located within its cyclic structure. In this design, cysteine and tyrosine synergistically chelate and reduce Au ions, while the confined protein structure restricts cluster growth, leading to the formation of a 25-gold atom (Au25) nanocluster with strong fluorescence and peroxidase-like activity. Unlike chemical ligands, protein scaffolds offer atomic-level precision and allow for site-specific modulation of the local environment through rational mutations, such as L9D, L9I, and E73I/L9I. This allows precise control of both fluorescence and enzymatic activity via protein engineering. Additionally, heteroatom doping of the Au core with copper endows the AuCEs with significant superoxide dismutase-like activity. Antioxidant assays demonstrate that the optimized AuCEs exhibit potent reactive oxygen species scavenging activity, providing significant protection to Caenorhabditis elegans from oxidative stress and highlighting their potential as therapeutic candidates for aging-related diseases.
- 28 July 2025
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 700 (Pt 3) , 138582
Mechanistic insights into redox-protonation coupled fluorescence switching in peptide-mediated gold nanoclusters for precision tumor imaging and resection
- 28 July 2025
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 700 (Pt 3) , 138582
Mechanistic insights into redox-protonation coupled fluorescence switching in peptide-mediated gold nanoclusters for precision tumor imaging and resection
- 26 January 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (5) , 6315-6326
Targeting and Microenvironment-Activated Nanoreactor for Diabetic Chronic Wound Healing via Multienzyme Cascade Reactions
The development of cell-like nanoreactors with the ability to initiate biocatalytic cascades under special conditions holds tremendous potential for therapeutic applications. Herein, conformationally gated nanoreactors that respond to the acidic microenvironment of infected diabetic wounds were developed by cucur[8]bituril (CB[8])-based supramolecular assembly. The bioinspired nanoreactors exhibit not only self-regulated permeability and selectivity to control internal enzyme activities by substance exchange but also distinct binding specificities toward Gram-positive and Gram-negative bacteria via noncovalent modification with different ligands. The encapsulation of glucose oxidase (GOx), Fe3O4 nanozyme, and l-arginine (l-Arg) into the nanocarriers enables intelligent activation of multienzyme cascade reactions upon glucose (Glu) uptake to produce gluconic acid (GA) and hydrogen peroxide (H2O2), which is further converted into highly toxic hydroxyl radicals (·OH) for selective antibacterial activity. Moreover, acidic H2O2 promotes the oxidization of l-Arg, leading to the release of nitric oxide (NO). Consequently, this nanoreactor provides a multifunctional and synergistic platform for diabetic chronic wound healing by combining enzyme dynamic therapy with NO gas therapy to combat bacterial infections and inflammation under high blood Glu levels.
- 26 January 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (5) , 6315-6326
Targeting and Microenvironment-Activated Nanoreactor for Diabetic Chronic Wound Healing via Multienzyme Cascade Reactions
The development of cell-like nanoreactors with the ability to initiate biocatalytic cascades under special conditions holds tremendous potential for therapeutic applications. Herein, conformationally gated nanoreactors that respond to the acidic microenvironment of infected diabetic wounds were developed by cucur[8]bituril (CB[8])-based supramolecular assembly. The bioinspired nanoreactors exhibit not only self-regulated permeability and selectivity to control internal enzyme activities by substance exchange but also distinct binding specificities toward Gram-positive and Gram-negative bacteria via noncovalent modification with different ligands. The encapsulation of glucose oxidase (GOx), Fe3O4 nanozyme, and l-arginine (l-Arg) into the nanocarriers enables intelligent activation of multienzyme cascade reactions upon glucose (Glu) uptake to produce gluconic acid (GA) and hydrogen peroxide (H2O2), which is further converted into highly toxic hydroxyl radicals (·OH) for selective antibacterial activity. Moreover, acidic H2O2 promotes the oxidization of l-Arg, leading to the release of nitric oxide (NO). Consequently, this nanoreactor provides a multifunctional and synergistic platform for diabetic chronic wound healing by combining enzyme dynamic therapy with NO gas therapy to combat bacterial infections and inflammation under high blood Glu levels.
- 1 December 2021
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1188, 339163
Sensitive ratiometric fluorescence probe based on chitosan carbon dots and calcein for Alkaline phosphatase detection and bioimaging in cancer cells
- 1 December 2021
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1188, 339163
Sensitive ratiometric fluorescence probe based on chitosan carbon dots and calcein for Alkaline phosphatase detection and bioimaging in cancer cells
- Open Access
Novel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Studies have shown that bradykinin (BK) is highly expressed in liver cancer. We designed the novel BK receptor inhibitors J051-71 and J051-105, which reduced the viability of liver cancer cells and inhibited the formation of cancer cell colonies. J051-71 and J051-105 reduced cell proliferation and induced apoptosis in HepG2 and BEL-7402 cells, which may be due to the inhibition of the extracellular regulated protein kinase (ERK) signaling pathway. In addition, these BK receptor inhibitors reversed the cell proliferation induced by BK in HepG2 and BEL-7402 cells by downregulating B1 receptor expression. Inhibiting B1 receptor expression decreased the protein levels of p-ERK and reduced the malignant progression of HCC, providing a potential target for HCC therapy.
Open AccessNovel Bradykinin Receptor Inhibitors Inhibit Proliferation and Promote the Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the ERK Pathway
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Studies have shown that bradykinin (BK) is highly expressed in liver cancer. We designed the novel BK receptor inhibitors J051-71 and J051-105, which reduced the viability of liver cancer cells and inhibited the formation of cancer cell colonies. J051-71 and J051-105 reduced cell proliferation and induced apoptosis in HepG2 and BEL-7402 cells, which may be due to the inhibition of the extracellular regulated protein kinase (ERK) signaling pathway. In addition, these BK receptor inhibitors reversed the cell proliferation induced by BK in HepG2 and BEL-7402 cells by downregulating B1 receptor expression. Inhibiting B1 receptor expression decreased the protein levels of p-ERK and reduced the malignant progression of HCC, providing a potential target for HCC therapy.